Prominent leaders and researchers discuss advances in genomics and multiomics technologies, including spatial proteomics for precision oncology and scaling single-cell genomics projects to enhance cell mapping and biological insight. Illumina CEO Jacob Thaysen outlines the company’s vision for multiomics leadership. New products launched by Qiagen, Spear Bio and Zymo Research improve sequencing and biomarker detection capabilities. Oxford Nanopore co-founder Clive Brown shares insights in a fireside chat, reflecting on transformative innovations in the field.